Physician profile
Michael E Lustgarten
NPI 1376525501
$1,132.07
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $147 · 2021: $642 · 2022: $126 · 2024: $24.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $306.28 | 2019-2022 | |
| Astellas Pharma US INC | $237.91 | 2019-2022 | |
| Pfizer INC. | $176.26 | 2019-2022 | |
| Myovant Sciences INC. | $146.78 | 2021 | |
| Endo Pharmaceuticals INC. | $100.15 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.24 | 2020-2021 | |
| Teleflex LLC | $24.99 | 2024 | Urolift |
| Tolmar Pharmaceuticals, INC. | $23.27 | 2019 | |
| Olympus America INC. | $16.11 | 2022 | |
| Photocure INC | $15.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lustgarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.